Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 51% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 5 institutions in 3 countries.
Hasan TürkezDepartment of Medical Biology, Faculty of Medicine, Atatürk University, 25240 Erzurum, Turkey.ORCID 0000-0002-7046-8990
Mehmet Enes ArslanDepartment of Molecular Biology and Genetics, Faculty of Science, Erzurum Technical University, 25240 Erzurum, Turkey.ORCID 0000-0002-1600-2305
Arzu TatarDepartment of Otorhinolaryngology, Faculty of Medicine, Atatürk University, 25240 Erzurum, Turkey.
Özlem ÖzdemirDepartment of Molecular Biology and Genetics, Faculty of Science, Erzurum Technical University, 25240 Erzurum, Turkey.ORCID 0000-0002-5472-8174
Erdal SönmezAdvanced Materials Research Laboratory, Department of Nanoscience & Nanoengineering, Graduate School of Natural and Applied Sciences, Atatürk University, 25240 Erzurum, Turkey.
Kenan ÇadirciDepartment of Internal Medicine, Erzurum Regional Training and Research Hospital, Health Sciences University, 25240 Erzurum, Turkey.
Ahmet HacimüftüoğluDepartment of Medical Pharmacology, Medical Faculty, Atatürk University, 25240 Erzurum, Turkey.
Bahattin CeylanDepartment of Medical Biology, Faculty of Medicine, Atatürk University, 25240 Erzurum, Turkey.
Metin AçikyildizDepartment of Chemistry, Faculty of Science and Art, Kilis 7 Aralık University, 79000 Kilis, Turkey.
Cigdem Yuce KahramanDepartment of Medical Genetics, Medical Faculty, Atatürk University, 25240 Erzurum, Turkey.ORCID 0000-0003-1957-9596
Fatime GeyikoğluDepartment of Biology, Faculty of Arts and Sciences, Atatürk University, 25240 Erzurum, Turkey.
Abdulgani TatarDepartment of Medical Genetics, Medical Faculty, Atatürk University, 25240 Erzurum, Turkey.
Adil MardinogluScience for Life Laboratory, KTH-Royal Institute of Technology, SE-17121 Stockholm, Sweden.ORCID 0000-0002-4254-6090
Atatürk University · TRErzurum Technical University · TRErzurum Regional Training and Research Hospital · TRKilis 7 Aralık University · TRKing's College London · GB
Funding
National Boron Research Institute (BOREN) Ç0391
6 · The paper itself
Abstract
Titanium diboride (TiB
Indexed as
human primary alveolar epithelial cell culturesin vitronanoparticlestitanium diboridetoxicogenomic responseszinc borate
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Molecular Genetics and Cytotoxic Responses to Titanium Diboride and Zinc Borate Nanoparticles on Cultured Human Primary Alveolar Epithelial Cells. · full record | OpenQuestion